Related references
Note: Only part of the references are listed.Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors
Mingfang Wu et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2017)
Physagulide Q suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells by regulating the ROS-JAK2/Src-STAT3 signaling pathway
Yan-Wei Yang et al.
RSC ADVANCES (2017)
Rapid and sensitive detection of microRNA via the capture of fluorescent Ayes-loaded albumin nangparticles around functionalized magnetic beads
Tianxiang Wei et al.
BIOSENSORS & BIOELECTRONICS (2017)
The prognostic value of serum LDH levels in patients with hepatocellualr carcinoma after hepatic resection
Wen-Jie Hu et al.
Anti-Cancer Agents in Medicinal Chemistry (2016)
Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter
Fu Wang et al.
NANOSCALE (2016)
Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death
R. Venkatadri et al.
CELL DEATH & DISEASE (2016)
Facile exfoliation of MoS2 nanosheets by protein as a photothermal-triggered drug delivery system for synergistic tumor therapy
Rui Deng et al.
RSC ADVANCES (2016)
Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability
A. A. Stepanenko et al.
GENE (2015)
Delivery strategies for sustained drug release in the lungs
Cristina Loira-Pastoriza et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells
Lingxia Tong et al.
ANTI-CANCER DRUGS (2014)
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial
Oriana Ciacio et al.
BMC CANCER (2014)
Resveratrol and cancer: focus on in vivo evidence
Lindsay G. Carter et al.
ENDOCRINE-RELATED CANCER (2014)
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery
S. Jose et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Advances in ophthalmic drug delivery
Thakur Raghu Raj Singh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats
Hua-Dong Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles
Hasan Kouchakzadeh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Acetal Derivatives as Prodrugs of Resveratrol
Andrea Mattarei et al.
MOLECULAR PHARMACEUTICS (2013)
PREPARATION OF FOLATE-CONJUGATED BOVINE SERUM ALBUMIN NANOPARTICLES ADSORBING EPIRUBICIN HYDROCHLORIDE
Xiuhua Zhao et al.
NANO (2013)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells
Karsten Ulbrich et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2
Shuguang Wang et al.
TOXICOLOGY IN VITRO (2011)
Erythropoietin Encapsulation in Chitosan Nanoparticles and Kinetics of Drug Release
M. Bokharaei et al.
CURRENT DRUG DELIVERY (2011)
Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies
Yu Zheng et al.
JOURNAL OF DRUG TARGETING (2009)
Resveratrol - A multitargeted agent for age-associated chronic diseases
Kuzhuvelil B. Harikumar et al.
CELL CYCLE (2008)
Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process
Jeong-Soo Kim et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor
Narendra P. Singh et al.
MOLECULAR PHARMACOLOGY (2007)
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles
Kyeongsoon Park et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer
D Delmas et al.
CURRENT DRUG TARGETS (2006)
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
D Koul et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Formation of ultrafine aspirin particles through rapid expansion of supercritical solutions (RESS)
Z Huang et al.
POWDER TECHNOLOGY (2005)
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs
MJ Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Share Paper
